BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 36281666)

  • 1. Adjudicating Mild Cognitive Impairment Due to Alzheimer's Disease as a Novel Endpoint Event in the TOMMORROW Prevention Clinical Trial.
    Schneider LS; Bennett DA; Farlow MR; Peskind ER; Raskind MA; Sano M; Stern Y; Haneline S; Welsh-Bohmer KA; O'Neil J; Walter R; Maresca S; Culp M; Alexander R; Saunders AM; Burns DK; Chiang C
    J Prev Alzheimers Dis; 2022; 9(4):625-634. PubMed ID: 36281666
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety and efficacy of pioglitazone for the delay of cognitive impairment in people at risk of Alzheimer's disease (TOMMORROW): a prognostic biomarker study and a phase 3, randomised, double-blind, placebo-controlled trial.
    Burns DK; Alexander RC; Welsh-Bohmer KA; Culp M; Chiang C; O'Neil J; Evans RM; Harrigan P; Plassman BL; Burke JR; Wu J; Lutz MW; Haneline S; Schwarz AJ; Schneider LS; Yaffe K; Saunders AM; Ratti E;
    Lancet Neurol; 2021 Jul; 20(7):537-547. PubMed ID: 34146512
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progression from Prodromal Alzheimer's Disease to Mild Alzheimer's Disease Dementia in the Verubecestat APECS Study: Adjudicating Diagnostic Transitions.
    Voss T; Kost J; Mercer SP; Furtek C; Randolph C; Lines C; Egan MF; Cummings JL
    J Alzheimers Dis; 2023; 92(1):341-348. PubMed ID: 36744336
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vitamin E for Alzheimer's disease and mild cognitive impairment.
    Isaac MG; Quinn R; Tabet N
    Cochrane Database Syst Rev; 2008 Jul; (3):CD002854. PubMed ID: 18646084
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The TOMMORROW study: Design of an Alzheimer's disease delay-of-onset clinical trial.
    Burns DK; Chiang C; Welsh-Bohmer KA; Brannan SK; Culp M; O'Neil J; Runyan G; Harrigan P; Plassman BL; Lutz M; Lai E; Haneline S; Yarnall D; Yarbrough D; Metz C; Ponduru S; Sundseth S; Saunders AM
    Alzheimers Dement (N Y); 2019; 5():661-670. PubMed ID: 31720367
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vitamin E for Alzheimer's dementia and mild cognitive impairment.
    Farina N; Llewellyn D; Isaac MGEKN; Tabet N
    Cochrane Database Syst Rev; 2017 Apr; 4(4):CD002854. PubMed ID: 28418065
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vitamin E for Alzheimer's dementia and mild cognitive impairment.
    Farina N; Llewellyn D; Isaac MG; Tabet N
    Cochrane Database Syst Rev; 2017 Jan; 1(1):CD002854. PubMed ID: 28128435
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vitamin E for Alzheimer's dementia and mild cognitive impairment.
    Farina N; Isaac MG; Clark AR; Rusted J; Tabet N
    Cochrane Database Syst Rev; 2012 Nov; 11(11):CD002854. PubMed ID: 23152215
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aspirin and other non-steroidal anti-inflammatory drugs for the prevention of dementia.
    Jordan F; Quinn TJ; McGuinness B; Passmore P; Kelly JP; Tudur Smith C; Murphy K; Devane D
    Cochrane Database Syst Rev; 2020 Apr; 4(4):CD011459. PubMed ID: 32352165
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of the End Point Adjudication Process on the Results of the Platelet-Oriented Inhibition in New TIA and Minor Ischemic Stroke (POINT) Trial: A Secondary Analysis.
    Farrant M; Easton JD; Adelman EE; Cucchiara BL; Barsan WG; Tillman HJ; Elm JJ; Kim AS; Lindblad AS; Palesch YY; Zhao W; Pauls K; Walsh KB; Martí-Fàbregas J; Bernstein RA; Johnston SC
    JAMA Netw Open; 2019 Sep; 2(9):e1910769. PubMed ID: 31490536
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estimated treatment effect of ticagrelor versus aspirin by investigator-assessed events compared with judgement by an independent event adjudication committee in the SOCRATES trial.
    Easton JD; Denison H; Evans SR; Knutsson M; Amarenco P; Albers GW; Ladenvall P; Minematsu K; Molina CA; Wang Y; Wong KL; Johnston SC;
    Int J Stroke; 2019 Dec; 14(9):908-914. PubMed ID: 31092152
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Souvenaid for Alzheimer's disease.
    Burckhardt M; Watzke S; Wienke A; Langer G; Fink A
    Cochrane Database Syst Rev; 2020 Dec; 12(12):CD011679. PubMed ID: 33320335
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rationale for the selection of dual primary endpoints in prevention studies of cognitively unimpaired individuals at genetic risk for developing symptoms of Alzheimer's disease.
    Caputo A; Racine A; Paule I; Tariot PN; Langbaum JB; Coello N; Riviere ME; Ryan JM; Lopez CL; Graf A; ;
    Alzheimers Res Ther; 2023 Mar; 15(1):45. PubMed ID: 36879340
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adjudication of cardiovascular events in patients with chronic obstructive pulmonary disease: SUMMIT trial.
    Wise RA; Anderson JA; Amarenco P; Cowans NJ; Crim C; Denvir MA; Gomez CR; Jones MP; Morris A; Niewoehner D; Yates JC
    Clin Trials; 2020 Aug; 17(4):430-436. PubMed ID: 32441114
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural magnetic resonance imaging for the early diagnosis of dementia due to Alzheimer's disease in people with mild cognitive impairment.
    Lombardi G; Crescioli G; Cavedo E; Lucenteforte E; Casazza G; Bellatorre AG; Lista C; Costantino G; Frisoni G; Virgili G; Filippini G
    Cochrane Database Syst Rev; 2020 Mar; 3(3):CD009628. PubMed ID: 32119112
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A hybrid automated event adjudication system for clinical trials.
    Yuan F; Bosch J; Eikelboom J; Dagenais GR; Connolly S; Belanger J; Marsden T; Tang C; Swaminathan B; Renters M; Dyal L; Bangdiwala SI
    Clin Trials; 2023 Apr; 20(2):166-175. PubMed ID: 36734212
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological and non-pharmacological interventions to enhance sleep in mild cognitive impairment and mild Alzheimer's disease: A systematic review.
    Blackman J; Swirski M; Clynes J; Harding S; Leng Y; Coulthard E
    J Sleep Res; 2021 Aug; 30(4):e13229. PubMed ID: 33289311
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.